MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case–control study and meta-analysis
Abstract
Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive. Aim: The purpose of this study was to investigate this hypothesis in a case–control study and meta-analysis in Iranian population. Materials & methods: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC. Results: Both case–control study and meta-analysis showed no association between rs1801133 and CRC risk or its features. Conclusion: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 . Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat. Res. 733(1–2), 21–33 (2012).Crossref, Medline, CAS, Google Scholar
- 2 . Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 34(1), 101–109 (2011).Crossref, Medline, CAS, Google Scholar
- 3 Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma Hcy concentrations. Circulation 93(1), 7–9 (1996).Crossref, Medline, CAS, Google Scholar
- 4 . The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients 5(9), 3481–3495 (2013).Crossref, Medline, Google Scholar
- 5 Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 12(5), 680–686 (2009).Crossref, Medline, Google Scholar
- 6 Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case–control studies involving 35,758 individuals. PLoS ONE 10(5), e0123423 (2015).Medline, Google Scholar
- 7 Folate deficiency induces dysfunctional long and short telomeres; both states are associated with hypomethylation and DNA damage in human WIL2-NS cells. Cancer Prev. Res. (Phila) 7(1), 128–138 (2014).Crossref, Medline, CAS, Google Scholar
- 8 . Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533(1), 11–20 (2014).Crossref, Medline, CAS, Google Scholar
- 9 Global cancer statistics, 2012. CA Cancer J. Clin. 65(2), 87–108 (2015). •• Meta-analyses of MTHFR gene polymorphism and colorectal cancer risk.Crossref, Medline, Google Scholar
- 10 . Polymorphisms and colorectal tumor risk. Gastroenterology 121, 282–301 (2001).Crossref, Medline, CAS, Google Scholar
- 11 . Relationship between metabolic enzyme polymorphism and colorectal cancer. World J. Gastroenterol. 11(3), 331–335 (2005).Crossref, Medline, CAS, Google Scholar
- 12 Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J. Hum. Genet. 52, 73–85 (2007).Crossref, Medline, CAS, Google Scholar
- 13 . MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int. J. Cancer 120, 1027–1035 (2007).Crossref, Medline, CAS, Google Scholar
- 14 Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am. J. Epidemiol. 170, 1207–1221 (2009).Crossref, Medline, CAS, Google Scholar
- 15 Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int. J. Cancer 128(3), 644–652 (2011).Crossref, Medline, CAS, Google Scholar
- 16 Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: a systematic review and meta-analysis. J. Cancer Epidemiol. 2012, 952508 (2012).Medline, Google Scholar
- 17 MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case–control studies. Mol. Biol. Rep. 39, 9669–9679 (2012).Crossref, Medline, CAS, Google Scholar
- 18 Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J. Natl Cancer Inst. 104, 1433–1457 (2013).Crossref, Google Scholar
- 19 MTHFR C677T polymorphism and colorectal cancer risk in Asians, a meta-analysis of 21 studies. Asian Pac. J. Cancer Prev. 13, 1203–1208 (2012).Crossref, Medline, Google Scholar
- 20 Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians. Tumour Biol. 33, 2041–2051 (2012).Crossref, Medline, CAS, Google Scholar
- 21 The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer. Int. J. Biol. Sci. 8(6), 819–830 (2012).Crossref, Medline, CAS, Google Scholar
- 22 Letter to the editor: a meta-analysis of MTHFR C677T polymorphism and colorectal cancer risk in east Asians. Int. J. Colorectal. Dis. 28(3), 429–430 (2013).Crossref, Medline, Google Scholar
- 23 The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies. PLoS ONE 8, e55332 (2013).Crossref, Medline, CAS, Google Scholar
- 24 Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: a meta-analysis. Biomed. Rep. 1(5), 781–791 (2013).Crossref, Medline, CAS, Google Scholar
- 25 Association of MTHFR C677T polymorphisms and colorectal cancer risk in Asians: evidence of 12,255 subjects. Clin. Transl. Oncol. 16(7), 623–629 (2013).Crossref, Medline, Google Scholar
- 26 5,10-methylenetetrahydrofolate reductase polymorphisms and colon cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 15(19), 8245–8250 (2014).Crossref, Medline, Google Scholar
- 27 . Evaluation of association studies and meta-analyses of MTHFR gene polymorphisms in colorectal cancer. Pharmacogenomics 16(4), 413–425 (2015).Link, CAS, Google Scholar
- 28 Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. Int. J. Epidemiol. 45(1), 186–205 (2015).Crossref, Medline, Google Scholar
- 29 . Evaluation of the MTHFR C677T polymorphism as a risk factor for colorectal cancer in Asian populations. Asian Pac. J. Cancer Prev. 16(18), 8093–8100 (2015).Crossref, Medline, Google Scholar
- 30 Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies. Tumour Biol. 36(11), 8953–8972 (2015).Crossref, Medline, CAS, Google Scholar
- 31 . Meta-prediction of MTHFR gene polymorphism mutations and associated risk for colorectal cancer. Biol. Res. Nurs. 18(4), 357–369 (2016). •• Previous original studies of MTHFR gene polymorphism in Iranian population.Crossref, Medline, CAS, Google Scholar
- 32 Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J. Gastroenterol. 14(23), 3662–3671 (2008).Crossref, Medline, CAS, Google Scholar
- 33 Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncol. Res. 18(2–3), 57–63 (2009).Crossref, Medline, CAS, Google Scholar
- 34 MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer Genet. Cytogenet. 197(2), 142–151 (2010).Crossref, Medline, CAS, Google Scholar
- 35 . Pathology of colorectal cancer. Clin. Oncol. (R. Coll. Radiol.). 19(10), 769–776 (2007).Crossref, Medline, CAS, Google Scholar
- 36 . The PRISMA statement: a guideline for systematic reviews and meta-analyses. J. Pediatr. Health Care 25, 1–2 (2011).Crossref, Medline, Google Scholar
- 37 Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 13, 50 (2006).Crossref, Google Scholar
- 38 Genetics, genomics, and cancer risk assessment state of the art and future directions in the era of personalized medicine. CA Cancer J. Clin. 61, 327–359 (2011).Medline, Google Scholar
- 39 Positive natural selection in the human lineage. Science 312(5780), 1614–1620 (2006).Crossref, Medline, CAS, Google Scholar
- 40 . Sample size and statistical power calculation in genetic association studies. Genomics Inform. 10(2), 117–122 (2012).Crossref, Medline, Google Scholar
- 41 Sample size requirements for structural equation models: an evaluation of power, bias, and solution propriety. Educ. Psychol. Meas. 76(6), 913–934 (2013).Crossref, Medline, Google Scholar

